Fierce biotech.com reports that the drug Zenvia developed by avanir pharmaceuticals, has recently shown successful phase 3 clinical trial results in its ability to relieve Pseudobulbar affect (PBA-(also known as involuntary emotional expression disorder (IEED) and emotional lability) in a subset of multiple sclerosis form of MS.
Reference
http://www.avanir.com/product/product.php?ID=11
http://www.fiercebiotech.com/story/avanir-stock-boosted-zenvia-data/2009-10-09
No comments:
Post a Comment